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Objective. We aim to investigate methods and use of cervical ripening in women without and with a prior cesarean delivery in
The Netherlands. Methods. In 2010, we conducted a postal survey in all Dutch hospitals with a labor ward. One gynecologist
per hospital was addressed and was asked to respond on behalf of the staff. The questionnaire contained 31 questions concerning
cervical ripening and induction of labor. We compared this survey to a similar Dutch survey conducted in 2006. Results. Response
rate was 78% (70/92 hospitals). In women without a prior cesarean and in need of cervical ripening, all hospitals (100%) applied
prostaglandins (either E1 or E2). In women with a prior cesarean, 21.4% of the hospitals performed an elective cesarean section if
delivery was indicated (26.0% in 2006). In case of cervical ripening, 72.7% used mechanical methods (49.1% in 2006), 20.0% used
prostaglandins (40.4% in 2006), 3.6% used a combination of prostaglandins and mechanical methods, and 3.6% used membrane-
sweeping or oxytocin. Conclusions. In 2010, in The Netherlands, prostaglandins and Foley catheters were the preferred methods
for cervical ripening in women without and with a prior cesarean, respectively. Use of mechanical methods in women with a prior
cesarean has increased rapidly between 2006 and 2010, corresponding with decreasing use of prostaglandins and elective repeat
cesarean sections.
1. Introduction
In 2007, 33% of all deliveries in The Netherlands were
induced [1]. It is estimated that more than half of the
women in whom labor is induced have an unfavorable cervix,
defined as a Bishop score less than 6 [2]. The national
guidelines of the Dutch Society of Obstetrics and Gynecol-
ogy (NVOG), the American College of Obstetricians and
Gynecologists (ACOG), the Royal College of Obstetricians
andGynaecologists (RCOG), and the Society ofObstetricians
and Gynaecologists of Canada (SOGC) advise the use of
prostaglandins for cervical ripening in this group of women
[3–6]. As an alternative, these guidelinesmention that a Foley
catheter can be used. However, the RCOG guideline states
that mechanical methods should not be used routinely, and
the SOGC guideline conveys that more data are needed to be
able to draw firm conclusions about their effectiveness [5, 6].
20% of all women with a prior cesarean delivery that
attempt a trial of labor in the subsequent pregnancy are
induced [7]. According to the Dutch (NVOG) guideline
on induction of labor, caution is advocated concerning the
use of contraction-stimulating drugs in women with a prior
cesarean section [8]. Internationally, there seems to be a lack
of consensus on the use of prostaglandins in women with a
prior cesarean delivery. The 2007 RCOG guideline recom-
mends a limit of 6mg for prostaglandin cervical ripening
[5]. The 2004 ACOG guideline states that appropriate case
selection and avoiding sequential prostaglandin and oxytocin
use offers the lowest risk of uterine rupture [9, 10]. The
2005 SOGC guideline advocates that prostaglandins should
only be used in exceptional situations and after appropriate
counselling [6]. Mechanical methods for cervical ripening
such as the Foley catheter seem to be a good alternative in
women with a prior cesarean delivery, carrying a lower risk
of uterine rupture compared to prostaglandins [11–13].
InThe Netherlands, both pharmacological and mechani-
cal methods of cervical ripening are applied, both in women
2 Obstetrics and Gynecology International
Table 1: Overview of survey respondents according to type of
hospital in The Netherlands in 2010.




Total number of respondents is 70; one survey was returned anonymously.
with and without a prior caeearean delivery. However, results
from the (2006) survey by Reijers et al. showed that mechan-
ical methods were rarely used [14].
Due to the (re)introduction of the Foley catheter in a
randomised controlled trial, the PROBAAT trial, conducted
in the Netherlands between February 2009 and May 2010,
awareness about and use of the Foley catheter have presum-
ably increased, especially in women with a prior cesarean
delivery. The PROBAAT trial comparing Foley catheter and
prostaglandins for cervical ripening in women without a
prior cesarean delivery showed that bothmethods are equally
effective with less maternal and neonatal side effects when
using the Foley catheter [15].
We conducted a nationwide survey to assess current
practice of cervical ripening in women with and without a
prior cesarean delivery in 2010. Results of the PROBAAT trial
were unknown at time of the survey.
2. Material and Methods
In April 2010, all 92 Dutch hospitals with an obstetric
practice received a postal questionnaire concerning methods
of cervical ripening in women with an unfavorable cervix.
One obstetrician per hospital was addressed and was asked
to reply on behalf of the hospitals obstetric staff and based
on protocols or policies.The survey consisted of two sections
concerning women without (part one) and with (part two)
a history of a cesarean delivery (S1). A total of 31 mul-
tiple choice questions with the opportunity for additional
comments were given. Both sections contained questions
concerning preferredmethod of cervical ripening, frequency,
and maximum daily dose of medication. Additionally, we
inquired if a difference in treatment was made between nulli-
and multiparous women. Respondents were asked whether a
cervical scoring system, such as the Bishop score, was used in
decisions concerning labor induction and cervical ripening
[2]. Methods of maternal and fetal monitoring and subse-
quent treatment after one and two days of cervical ripening
were inquired. In part two, respondents were additionally
asked if there were any reasons not to induce labor or apply
cervical ripening in women with a prior cesarean delivery.
Nonrespondents received a reminder email after six
weeks and, if necessary, a phone call two weeks later.
Our results were compared to the (2006) survey on
induction of labor in women with an unfavorable cervix
by Reijers et al. for both women without and with a prior
cesarean delivery [14].The questions posed in the 2010 survey
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Figure 1: Minimum Bishop score after cervical ripening required
for induction of labor by amniotomy and oxytocin augmentation
in women without and with a prior cesarean delivery in The
Netherlands in 2010. Missing value: 𝑛 = 1.
We compared the use of cervical ripening and methods
for cervical ripening between 2006 and 2010. For categorical
or dichotomous data differences were tested using the chi-
square test. All analyses were performed using SPSS version
17.0 (SPSS Inc, Chicago, IL, USA).
3. Results
Of the 92 surveys sent 70were returned, giving a response rate
of 78%. Respondents according to type of hospital are shown
in Table 1.
3.1. Part One: Women without a Prior Cesarean Delivery
3.1.1. Cervical Ripening Methods. An overview of the various
methods of cervical ripening of the unfavorable cervix in
women without a prior cesarean delivery is shown in Table 2.
Also, doses and maximum frequency of administration are
specified for the preferred method of cervical ripening.
Twenty-five hospitals (36%) used more than one method
for cervical ripening. If applicable, the second preferred
method is also shown. Two hospitals adjusted dose of vaginal
prostaglandin E2 gel according to parity.
For the assessment of cervical ripeness and the con-
sequent decision of cervical ripening and induction, 48
hospitals (69%) used a cervical scoring system such as
the Bishop score. The remaining hospitals assessed cervical
ripeness using a vaginal examination, without a specified
scoring system. Of the 47 hospitals that used the Bishop
score, induction after cervical ripening by amniotomy and
oxytocin augmentation was performed at a certain Bishop
score (Figure 1). Six of the 22 hospitals (27%) that did not
use the Bishop score performed amniotomy at a lower “score”
of their own scoring system in multiparous compared to
nulliparous women when a “favorable” cervix was found by
vaginal examination.
























































































































































































































































































































































































































































































































4 Obstetrics and Gynecology International
All hospitals applied fetal monitoring at set times after
starting cervical ripening. Two hospitals (3%) applied contin-
uous fetal monitoring with cardiotocography (CTG) during
cervical ripening with vaginal prostaglandin E2 gel (1 and
2mg). Induction of labor by amniotomy and subsequent
oxytocin augmentation after proven cervical ripeness was
performed at any moment of the day in 35 hospitals (50%),
themorning after the start of cervical ripening in 29 hospitals
(41%), and depended on the indication of induction in 5
hospitals (9%).
The most reported reasons for the preferred method of
cervical ripening were “ease in use” (57%), “reduced hyper-
stimulation risk” (24%), and “increased likelihood of delivery
within 24 hours” (19%). The arguments “ease in use” and
“reduced hyperstimulation risk” were predominantly men-
tioned by hospitals that used prostaglandin E2 gel or a slow
release prostaglandin E2 vaginal insert. The argument “more
deliveries in 24 hours” was given by all three hospitals that
use the Foley catheter in combination with prostaglandins.
Other important arguments were “tradition,” “experience”
and, among slow release prostaglandin E2 vaginal insert
users, “the possibility of removing it.”
The policy after insufficient result of cervical ripening
after one or two days is shown in Table 3.
3.2. Part Two: Women with a Prior Cesarean Delivery
3.2.1. Reasons for Not Inducing Labor in Women with a
Prior Cesarean Delivery. None of the hospitals strived for a
vaginal birth after cesarean (VBAC) inwomenwith a classical
incision at the prior cesarean delivery, and 53 hospitals (76%)
did not pursue a VBAC in women with more than one
prior cesarean delivery. A prior cesarean delivery before a
gestational age of 34 weeks and no prior vaginal deliveries
were relevant in the decision not to attempt a trial of labor
in two hospitals.
When induction of labor was required, VBAC was not
pursued in nonvertex position in 51 hospitals (73%), in an
unfavorable cervix in 28 hospitals (40%), in a nonengaged
head in 25 hospitals (36%), or in a twin pregnancy in 11
hospitals (16%).
In cases in which a prompt delivery was desired, eight
hospitals (11%) performed an elective cesarean section.When
labor was induced inwomenwith a prior cesarean delivery, 14
hospitals (20%) had a different policy concerning induction
of labor in women with and without a prior vaginal delivery.
3.2.2. Cervical Ripening Methods. Cervical ripening in
women with a prior cesarean delivery and an unfavorable
cervix was done using various methods. Fifteen hospitals
(21.4%) did not use cervical ripening in case of an unfavor-
able cervix but planned an elective repeat cesarean section
(ERCS). Of the 55 hospitals that applied cervical ripening, 40
hospitals (72.7%) used mechanical methods; 2 hospitals used
a hygroscopic cervical dilator (Dilapan-S), and 38 hospitals
used a Foley catheter, including three hospitals using it in
combination with oxytocin. Two of the 55 (3.6%) hospitals
used a Foley catheter in combination with prostaglandins
(oral E1 tablet 50mcg 𝑛 = 1, cervical prostaglandin E2 gel
0.5mg 𝑛 = 1), and two other hospitals (3.6%) usedmembrane
sweeping or oxytocin only. Eleven hospitals (20%) used
prostaglandin analogues. Specifications are shown in Table 4
including the frequency of administration and maximum
daily doses, specified for the preferred method of cervical
ripening. Seventeen hospitals (30%) used more than one
method of cervical ripening.
In 49% of the hospitals, the method of cervical ripening
has changed over the past five years. The reason most
frequently mentioned were “evidence from the literature
concerning an elevated risk of uterine rupture with the use
of prostaglandins” (𝑛 = 21) and “the reintroduction of the
Foley catheter” (𝑛 = 5).
According to the hospitals that applied cervical ripening
in women with a prior cesarean delivery (𝑛 = 55), their
motivations for the method of choice were “reduced hyper-
stimulation risk” (𝑛 = 12), “easy in use” (𝑛 = 6), “more
deliveries in 24 hours” (𝑛 = 2), and “less fetal distress” (𝑛 = 1).
Sixteen hospitals mentioned that their method was preferred
“for different reasons”, and 13 gave a combination of reasons,
10 including “reduced hyperstimulation risk.” Five hospitals
gave no motivation for the use of their preferred method.
For the assessment of cervical ripeness and the conse-
quent decision of cervical ripening and induction, 35 of the
55 hospitals (64%) used a cervical scoring system such as
the Bishop score. Of the 35 hospitals that used the Bishop
score, induction after cervical ripening by amniotomy and
oxytocin augmentation was performed at a certain Bishop
score (Figure 1). Out of the 20 hospitals that did not use a cer-
vical scoring system, the decision to perform amniotomy was
based on the ease in which the membranes could be reached
in five hospitals. Six hospitals reported that a minimum of
2 cm dilatation was required to perform amniotomy.
Continuous fetal monitoring was applied in 16 hospi-
tals of which 10 used the Foley catheter and four used
prostaglandin E2 gel. Amniotomy and subsequent oxytocin
augmentation after proven cervical ripeness were performed
at any moment of the day in 21 hospitals (38%), the morning
after in nine hospitals (16%), and depended on the indication
of induction in eight hospitals (15%).
The policy after insufficient result of cervical ripening
after one or two days is shown in Table 5.
3.3. Comparison: Cervical Ripening in Women with and
without a Prior Cesarean Delivery. When comparing cervical
ripening in women with and without a prior cesarean
delivery, fetal monitoring using CTG was conducted more
frequently in women with a prior cesarean delivery. Women
with a prior cesarean delivery were monitored continuously
in 16 hospitals compared to two hospitals for women without
a prior cesarean delivery. The timing of amniotomy and
subsequent oxytocin augmentation hardly differed between
women without or with a prior cesarean delivery. However,
the timing of amniotomy and oxytocin augmentation in
women with a prior cesarean delivery seemed less influenced
by the indication of induction (15 versus 27%) or the presence
of contractions (4 versus 11%). Two hospitals did not perform
amniotomy after a specific time (16.00 hrs and 24.00 hrs) if
the parturient was not in labor.
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The use of a cervical scoring system was nearly equal
in women with (69%) and without (64%) a prior cesarean
delivery.
3.4. Comparison with Survey Conducted in 2006. Similar to
the 2006 survey (response rate 94%, 𝑛 = 77/82), there was
a great variety in methods of cervical ripening in 2010. In
women without a prior cesarean delivery, all hospitals in
2010 used prostaglandins as preferred method for cervical
ripening, as was the case in 2006.
Concerning women with a prior cesarean delivery, 72.7%
(40/55) of the hospitals that allowed induction of labor used
mechanical methods for cervical ripening in 2010 compared
to 49.1% (28/57) in 2006 (𝑃 < 0.05). The Foley catheter
specifically was used two and half times more often in 2010
(69.1% versus 25%, 𝑃 < 0.01). The use of prostaglandins in
cervical ripening in women with a prior cesarean decreased
from 40% in 2006 to 20% in 2010 (𝑃 < 0.05).
There was a nonsignificant decrease in the percentage
of hospitals that did not apply cervical ripening and thus
performed an ERCS in 2010 (21% versus 26%).
Of the six hospitals that did not apply cervical ripening
in 2006 and returned both the 2006 and 2010 surveys, four
switched to Foley catheter use, one to dilapan and one to
prostaglandin E2 gel in 2010. Of the twelve hospitals that
did not apply cervical ripening in 2010 and returned both
the 2006 and 2010 surveys, two hospitals used dilapan, one
used intracervical prostaglandin E2 gel, and one used the
foley catheter for cervical ripening in 2006. Twenty out of
21 hospitals that participated in the PROBAAT study in 2010
returned the survey, revealing that 70% (14/20) used the Foley
catheter, 15% (3/20) used prostaglandins, and 15% (3/20) did
not offer induction of labor in women with a prior cesarean
delivery.
Although all respondents in 2006 felt that theirmethod of
cervical ripening was easiest in use and led to more deliveries
in 24 hours, the respondents in 2010 mostly mentioned
“easy in use” and “less hyperstimulation” in response to the
question why their preferredmethod of cervical ripening was
superior.This survey showed an increase in use of the Bishop
score from 39% in 2006 to 69% in 2010 (𝑃 < 0.01).
4. Discussion
With a response rate of 78%, this survey gives a representative
view of the current methods of cervical ripening in the
Netherlands, showing a great variety in methods of cervical
ripening.
The use of intracervical prostaglandin gel has declined
over the years, whereas the use of vaginal misoprostol has
increased. It is striking that the Foley catheter is never used
as the preferred method of cervical ripening, neither in 2006
nor in 2010. As the results of the PROBAAT trial 15 were not
yet known, it is possible that hospitals were waiting for the
results of this trial before changing their preferred method of
cervical ripening.
The decrease of ERCS and the increase in use of the
Foley catheter in women with a prior cesarean delivery are
most likely due to the decreased popularity of prostaglandins
and the (re)introduction of the Foley catheter through recent
randomized controlled trials including the PROBAAT trial
[15, 19]. Furthermore, the results of the studies of Kwee et
al. and Lydon-Rochelle et al., in which an increased risk of
uterine rupture was found when prostaglandins were used in
this group, may have discouraged the use of prostaglandins
in these women [7, 9].
The nationwide variety in methods of cervical ripening
is not surprising, especially when we bear in mind the lack
of evidence and recommendations in the Dutch guideline on
induction of labor in which different methods are mentioned
to have similar effectiveness and safety profiles [4]. This may
also be the basis for the use of more than one method for
cervical ripening in 25 hospitals (36%), probably showing
that tradition, culture, experience, and personal preference of
gynecologists are of influence on methods used.
It seems that hospitals are increasingly concerned with
safety of induction instead of the speed of delivery. How-
ever, standardisation of medical procedures and prescrip-
tions reduces medication errors [20–22]. Therefore, a clearly
defined, written local protocol on induction of labor includ-
ing evidence-based methods of induction which are effective
and safe would be advisable.
TheDutch guideline on induction recommends the use of
the Bishop score for cervical assessment, but also points out
that it remains a subjective method [4]. In both surveys there
is a great variation in the (Bishop) score at which the cervix
is deemed favorable for amniotomy and subsequent oxytocin
augmentation.
All hospitals applied fetal monitoring at set times after
starting cervical ripening, although length and frequency
differed. Again, the lack of evidence and uniformity in the
literature and in guidelines is reflected in the wide variety
of clinical practice. While the guideline does not mention
timing or frequency of fetal monitoring, all hospitals seem
to have a local protocol to which they adhere.
Although amniotomy and subsequent oxytocin augmen-
tation were performed at anymoment of the day in half of the
hospitals, a substantial part of hospitals waited until the next
day to continue induction. Sometimes, it was also dependent
on the indication for induction or the presence of contrac-
tions. Whether or not the attention in the media for the
publication by de Graaf et al. on increased adverse perinatal
outcome of hospital delivery at night influenced this decision
remains unclear [23]. Furthermore, the Dutch guideline
advocates an interval of 6 to 12 hours after cervical ripen-
ing using PGE2 analogues before performing amniotomy
because of the risk of potentiation.These phenomena may be
the basis for 29 hospitals (41%) to wait until the next day to
continue induction and that two clinics discontinued after a
certain hour unless strictly necessary.
Although 28 hospitals answered positively to the question
whether or not an unfavorable cervix was a reason not to
induce labor in women with a prior cesarean delivery, only
15 hospitals declared not to apply cervical ripening in women
with a prior cesarean delivery. Possibly the question was not
written clearly or misread.
Limitations of this study are that this survey was sent
to only one gynecologist per hospital, which may introduce
Obstetrics and Gynecology International 9










Use of ARM Willingness touse oxytocin
England 2011∗ [16] 67% (322/480) 7% (22/322) 76% (229/300) 3% (9/300) 21% (62/300) unknown
Australia, NZ 2003∗∗ [17] 67% (1091/1641) 32% (349/1091) 33% (360/1091) unknown unknown 73% (796/1091)
Canada 2003∗∗∗ [18] 50% (750/1497) 9% (54/601) 25% (150/601) unknown unknown unknown
The Netherlands 2010 78% (70/92) 21% (15/70) 20% (11/55) 73% (40/55) 4% (2/55) unknown
NZ: New Zealand; CS: cesarean section; ARM: artificial rupture of membranes.
∗Among 480 NHS obstetric consultants.
∗∗Among fellows and members of the Royal Australian and New Zealand College of Obstetricians and Gynecologists.
∗∗∗Among all obstetricians registered with the Canadian Medical Directory.
bias. Results may be affected by the subjective perception
and practice of that particular gynecologist. However, the
responding gynecologist was asked to answer on behalf of the
staff and based on protocols or policies.
It remains unclear what the maximum period of induc-
tion was for the different hospitals; that is, which definition
of failed induction they used. At the time of the survey,
several hospitals (28.5% of the respondents) participated in
the PROBAAT trial, in which failed inductionwas considered
after 4 days. It is likely that the participating hospitals of the
PROBAAT trial used this definition [15].
The incidence of uterine rupture in 2002 in the Nether-
lands was 0.8% in women with a prior cesarean delivery
undergoing a trial of labor without contraction-stimulating
drugs and 1.47% in all women [7]. Another Dutch study
reported an estimated risk of uterine rupture to be 0.64% in
these women undergoing a trial of labor between 2004 and
2006 [24]. Although several studies suggest an increased risk
of uterine rupture in the use of PGE2 analogues, a review in
2006 did not convey a negative advice due to lack of evidence
[9, 25–27].TheDutch guideline does not discourage their use
but merely suggests that the elevated risk of uterine rupture
when using contraction-stimulating drugs should beweighed
and discussed with the women [8]. It is remarkable that in
the case of cervical ripening of women with a prior cesarean
delivery, policies concerning induction of labor differ so
greatly between hospitals.
5. International Comparison of Induction of
Labor in Women without or with a Prior
Cesarean Delivery
Wewere unable to identify other surveys of practice concern-
ing methods of cervical ripening in women without a prior
cesarean delivery.
Comparison of the results of our study with surveys from
the UK, Australia New Zealand, and Canada shows that
the use of prostaglandins for cervical ripening in women
with a prior cesarean delivery is by far the lowest in the
Netherlands (20%) [16–18]. Also, cervical ripening using
mechanical methods in this group is much more popular in
the Netherlands (73%) compared to England (3%) (Table 6).
However, it should be noted that the data span 2003 to
2011 making this comparison difficult since many changes in
practice concerning prostaglandin use in women with a prior
cesarean delivery have been made over the last decade.
We recommend repeating this survey (inter)nationally
to assess whether or not results of the PROBAAT trial have
influenced policy concerning cervical ripening.
6. Conclusions
There is a large diversity in methods of cervical ripening in
the Netherlands. In women without a prior cesarean delivery
prostaglandins aremost frequently used, which is in line with
other countries. In women with a prior cesarean delivery,
the Foley catheter is most often used, which is in contrast
to other high-income countries where prostaglandins are
mainly used. Although the Foley catheter has become more
popular in cervical ripening in women with a prior cesarean
delivery, the overall policy in these women is still diverse,
and prospective comparisons of different induction methods
in these women are lacking. We conclude that a study
concerning safety and effectiveness of the Foley catheter for
cervical ripening in women with a prior cesarean delivery is
recommended.
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